Beat The Denominator

Investors should consider MicroStrategy (MSTR) as the stock shows signs of bottoming after a recent recovery, supported by strong shareholder alignment and a stabilizing Market Net Asset Value (mNAV). For those seeking high-yield income, the STRC preferred instruments and junior debt offer "unbeatable" tax-deferred yields of up to 14.57%. Bitcoin (BTC) is currently in a "high fear" accumulation phase near $63,000, providing a strategic entry point for long-term investors before a potential market reversal. You can choose between the high-beta growth potential of MSTR common stock or the steady cash flow of its perpetual debt instruments depending on your risk tolerance. This entire strategy serves as a leveraged bet on Bitcoin becoming a global reserve asset, which would eventually allow the company to refinance its high-interest debt at much lower rates.

Investors should consider Novo Nordisk (NVO) as a high-conviction value play, currently trading at a significant discount with a low 9.8x P/E ratio and a 4% dividend yield. While Eli Lilly (LLY) is the current growth leader with superior triple-pathway drugs expected by 2027, NVO offers better risk-adjusted entry points as it scales manufacturing for its upcoming CagriSema and oral pill offerings. For diversified exposure to the mass-market shift in weight-loss treatments, build a "basket" of NVO, LLY, and Hims & Hers Health (HIMS) rather than buying diluted sector ETFs. Monitor NVO for potential price dips caused by geopolitical "tariff scares," which may provide attractive buying opportunities regardless of the company's strong 53% EBITDA margins. Focus on the transition from injections to oral GLP-1 pills, as this form factor is expected to drive massive adoption toward the goal of 1 in 3 Americans using these drugs by 2030.

Investors should view MicroStrategy (MSTR) as a high-conviction play on Bitcoin (BTC), especially as the company continues aggressive accumulation with a recent purchase of 1,550 BTC at an average price of $65,300. While MSTR often trades at a premium to its net asset value, this "Bitcoin yield" strategy allows the company to use its $1 billion cash reserve and equity offerings to increase scarcity for all holders. Retail investors should note that the "real" price for large-scale institutional BTC acquisition is currently 10%–15% higher than exchange spot prices, signaling strong underlying demand. For short-term direction, monitor the Nasdaq and cooling oil prices, as these macro factors are the primary drivers for a potential market rebound. Ignore social media "Black Monday" scares regarding international markets like the KOSPI, as these often reflect time-zone lags rather than new fundamental risks.

Investors should exercise caution with Enphase Energy (ENPH) as its core residential solar revenue has flatlined and its strategic pivot into AI data centers won't see volume shipments until 2028. While the company’s shift to Gallium Nitride (GaN) technology and IQ9 microinverters offers long-term technical superiority, the recent price spike appears overextended relative to current -1% revenue growth. Avoid chasing the "AI hype" in the short term, as high interest rates and the loss of IRA tax credits continue to weigh heavily on the solar sector. Instead, monitor the broader AI Power Infrastructure theme for companies providing high-efficiency AC-to-DC power management for data centers. For those with a multi-year horizon, look for entry points into ENPH only after the current valuation cools or interest rates begin a sustained decline.

Investors should look for a potential floor in Bitcoin (BTC) near the $55,000 level, as current bearish sentiment and liquidations may have exhausted the pool of sellers. While MicroStrategy (MSTR) remains a high-risk play with a 1.5x correlation to BTC, ignore bankruptcy rumors and monitor their equity program for signs of strategic accumulation. For income-focused investors, the STRC (Stretch) yield instrument offers a contrarian opportunity with a tax-deferred yield expected to rise toward 12%. Compare recent volatility in crypto to high-growth AI stocks like Broadcom (AVGO) to determine if price drops are asset-specific or part of a broader "risk-off" macro environment. Given that markets are pricing in an 80% chance of zero rate cuts in 2024, prioritize patience and wait for a resolution in Middle East tensions or inflation data before increasing exposure.

Investors should avoid Rocket Lab (RKLB) and Intuitive Machines (LUNR) at current levels, as their valuations have reached "nosebleed" territory driven by unsustainable hype rather than fundamentals. For a safer entry into the sector, AeroVironment (AVAV) is a top bullish pick, offering a "cheap" valuation with an EV/GP/RG of 0.18 and strong revenue from military drone contracts. KULR Technology Group (KULR) represents a high-conviction value play with a potential 10x return target of $37.00, supported by a strong balance sheet and a significant Bitcoin treasury. Be cautious of Redwire (RDW) and Black Sky (BKSY), as both face high operational risks and potential disruption from SpaceX's market dominance. Focus on companies with an EV/GP/RG below 0.20 to ensure a margin of safety in this highly speculative space economy.

Avoid participating in the initial SpaceX IPO, as retail allocations are expected to be inefficiently small and the stock will likely experience significant post-listing volatility. Instead, wait for a "Black Swan" event or a major technical setback to provide a lower-risk entry point during a sharp price drawdown. Long-term investors should consider shorting or reducing exposure to traditional telecommunications providers like AT&T (T) and Verizon (VZ), which face disruption from Starlink’s satellite-to-cell technology. Focus your space-sector portfolio on infrastructure "rails" like Rocket Lab (RKLB) and companies specializing in launch, refueling, and data transport rather than pure exploration. Maintain healthy cash reserves to capitalize on healthy corrections in Magnificent 7 stocks like Nvidia (NVDA) and Microsoft (MSFT), which remain strong long-term plays despite short-term market noise.

Maintain a high cash reserve and limit new purchases to small increments 3–4 times per month to survive a market driven by "vibes" rather than fundamentals. Use extreme intraday drawdowns in high-conviction names like Broadcom (AVGO) and Meta (META) as potential entry points, but prepare for "Black Swan" volatility of 4-8% in a single day. View Hims & Hers Health (HIMS) as a resilient play due to its inelastic, subscription-based business model, despite recent irrational sell-offs. Monitor Bitcoin (BTC) as a benchmark for systemic liquidity, as it currently shows lower relative volatility than many high-growth semiconductor stocks. Avoid slow accumulation strategies for fast-moving leaders like Micron (MU) and Nvidia (NVDA), as these assets often skyrocket or crash before traditional positions can be fully built.

The current market sell-off has made NVIDIA (NVDA) exceptionally cheap relative to its blockbuster revenue growth, offering a high-conviction entry point for long-term investors. While MicroStrategy (MSTR) is experiencing significant volatility, the company faces no immediate margin calls or debt maturities until 2027, making the current "dump" an irrational reaction to macro fears. Tesla (TSLA) remains a volatile "casino" play, but it has the potential to rebound to a $250 price target as early as next week if geopolitical tensions ease. For those seeking lower risk, prediction markets like Polymarket offer a high-probability opportunity to bet against a MicroStrategy bankruptcy over the next six months. Ultimately, investors should ignore short-term "market madness" in Bitcoin (BTC) and tech leaders, as the fundamental thesis for these assets remains intact despite the temporary flight to defensive stocks like Coca-Cola (KO).

Investors should consider a long-term position in Hims & Hers Health (HIMS) as it pivots toward the high-growth longevity market through the introduction of peptides and GLP-1s. Despite recent gains, HIMS remains undervalued compared to other disruptors, with a projected valuation gap suggesting a price target between $70 and $80. For a medium-term opportunity, Oscar Health (OSCR) offers significant upside as it leverages AI efficiency and aggressive premium hikes to drive an estimated 61% revenue growth. Monitor OSCR through the next earnings cycle, as a continued low Medical Loss Ratio (MLR) could trigger a formal guidance raise and further price appreciation. Both HIMS and OSCR represent a broader shift toward HealthTech disruption, offering "recession-resistant" recurring revenue models that are currently discounted by traditional finance.

Investors should monitor MicroStrategy (MSTR) for price stabilization near the $121 level, as current market capitulation and extreme bearish sentiment often signal a potential bottom. Bitcoin (BTC) appears to be moving inversely to energy markets; watch for further drops in oil prices as a tactical entry signal for a BTC rebound toward previous highs. For those seeking yield, Bitmine (BMNR) is launching a preferred stock with an 8.5% yield, though investors should weigh this return against the underlying risks of its Ethereum holdings. Capital is currently rotating out of crypto and into AI and SpaceX, so look for a reversal in this trend or a stabilization in Solana (SOL) as it sits in a "valley of despair." The broader "Short Fiat" strategy remains high conviction, suggesting that companies using preferred stock to acquire hard assets like BTC are positioned to outperform as the US Dollar devalues.

With the Bitcoin (BTC) Fear and Greed Index at "Extreme Fear" (11), current prices near $64,700 represent a high-conviction entry point before psychological support at $63,000. MicroStrategy (MSTR) is a primary buy-the-dip candidate at $126, as the company holds 10x the cash required to cover debt obligations, making social media "margin call" rumors fundamentally false. Investors should ignore short-term volatility driven by market makers and instead view BTC as a superior liquidity hedge compared to crashing government bonds or illiquid real estate. Beyond crypto, look for contrarian opportunities in undervalued fintech disruptors like SoFi (SOFI), Hims & Hers (HIMS), and the BNPL sector. Expect high volatility to persist through 2029, but use this period of "total nonsense" selling to accumulate assets that traditional rating agencies currently misunderstand.

NVIDIA (NVDA) is currently the top-tier "buy" with a valuation score of 0.46, offering elite 61% revenue growth that makes it significantly cheaper than competitors like AMD. Meta Platforms (META) is the second high-conviction opportunity, trading at a discount with a 51% EBITDA margin and new growth catalysts from Meta AI and hardware. Investors should consider Amazon (AMZN) as a secondary play, though its heavy capital expenditures in AWS mean the investment thesis may take longer than a year to fully materialize. Avoid Apple (AAPL) at current levels, as its 2.0 valuation score makes it four times more expensive than NVDA relative to its modest 10% growth. Tesla (TSLA) remains a high-risk "special situation" where major financial catalysts like RoboTaxi are not expected to impact the bottom line until 2028 or later.

Investors should view the current Bitcoin (BTC) price suppression as a high-conviction buying opportunity, as the asset remains fundamentally undervalued with a long-term target in the hundreds of thousands. To avoid being wiped out by exchange-driven volatility and liquidations, retail investors must avoid high-leverage perpetual futures and maintain a portfolio that can withstand a potential drop to $50,000. For those seeking exposure to the ecosystem with lower volatility, MicroStrategy (MSTR)-linked fixed-income products offer a "deep value" alternative that historically experiences significantly smaller drawdowns than spot crypto. While MSTR equity remains a volatile "refinery" for accumulating more BTC, the current price dip is viewed as a temporary dislocation rather than a shift in the company's successful financial engineering strategy. Ultimately, investors should rotate toward hard assets like Bitcoin to prepare for an inevitable surge in global M2 money supply and macro liquidity.

Investors should consider Hims & Hers Health (HIMS) as a primary disruptor in the telehealth space following its early acquisition of Eucalyptus, which expands its global footprint and pushes total subscribers past 3 million. Analysts expect a significant upward revision to long-term revenue targets during the Q2 earnings report, with 2026 sales potentially reaching $3.16 billion due to this international expansion. The stock is currently viewed as undervalued with an EV/Gross Profit/Growth metric of 0.1, offering a high-conviction entry point while the market lags behind these fundamental developments. Beyond core treatments, HIMS remains a leader in the high-growth GLP-1 weight loss market, successfully navigating previous legal concerns to maintain its competitive edge against peers like LifeMD (LFMD). For a diversified play on the digital healthcare shift, focus on "full-stack" providers like HIMS that control the entire patient experience from the mobile app to pharmacy fulfillment.

The current "Extreme Fear" in the crypto market presents a high-conviction contrarian buying opportunity for Bitcoin (BTC) as it decouples from overextended tech stocks. Investors looking for higher beta should consider MicroStrategy (MSTR), which is currently trading at a discounted entry point but carries 1.5x leverage volatility relative to BTC. For capital preservation and steady income during this downturn, STRC is a recommended alternative that has significantly outperformed BTC on a relative basis. Position yourself in STRC before July 15th to capture the upcoming dividend payment while the broader market remains volatile. Avoid chasing the AI boom in tickers like NVIDIA (NVDA) or Micron (MU), as their rapid price appreciation has outpaced revenue growth, making them higher-risk entries compared to the depressed crypto sector.

Avoid chasing the recent rallies in Hyperliquid (HYPE) and Nebius (NBIS), as both assets require at least a 30% correction to reach attractive entry points. Instead, pivot to SoFi Technologies (SOFI), which is currently down 42% from recent highs and represents a "coiled spring" with a long-term price target of $30. For deep value, Hims & Hers Health (HIMS) and Real Brokerage (REAX) are considered "dirt cheap" opportunities where market skepticism over acquisitions has created significant valuation gaps. Investors seeking high-growth international exposure should look at Kaspi.kz (KSPI) for its 8% dividend yield or MercadoLibre (MELI), which is currently trading at a more attractive valuation than NuBank. Finally, Meta Platforms (META) remains the highest conviction "anchor" for any portfolio, offering the cheapest entry point among the Magnificent 7 with strong catalysts in AI and hardware.

Investors should view the recent price drop in Bitcoin (BTC) toward $71,300 as a fundamental buying opportunity, as the decline is driven by temporary Middle East geopolitical tensions rather than network weakness. Monitor MicroStrategy (MSTR) closely following its $800 million capital raise; a deployment into more Bitcoin would confirm a high-conviction bullish signal for the stock. Ignore the "noise" of recent small BTC sales by MSTR, as these were likely regulatory proof-of-concept liquidations rather than a shift in long-term strategy. If regional escalations continue, be prepared for a potential BTC price floor near $69,000, which may offer an even more attractive entry point for long-term holders. For those with high-cost bases, consider tax-loss harvesting on recent crypto dips to offset capital gains in outperforming sectors like Semiconductors.